Principal Investigator

Administrative Assistant

Post Docs

Ray Lee
Ishaq N. Khan
Postdoctoral Associate, MIT Media Lab

Khan is a cancer biologist working with Prof. Deblina Sarkar on developing novel therapeutic strategies for tumors which are resistant to standard treatments. Prior joining NCB, he worked as a postdoctoral research associate at Texas A&M Health Science Center, on developing novel small molecule kinase inhibitors for breast cancer brain metastasis with Prof. Alyismail from Irma Lerma School of Pharmacy. Before joining Texas A&M University, Khan worked as an Assistant professor at Khyber Medical University, where he established the only national brain tumors biobank from 350+ patients, with comprehensive clinical data including radiological scans, histopathological reports, biochemical, and hematological profiles. As PI of the Precision Oncomedicine Lab (C3POL), Khan retrieved cancer tissues, blood, DNA, RNA, and generated primary cell cultures from wide range of adult and pediatric brain tumors’ patients including meningiomas, medulloblastomas, pituitary tumors, schwannomas, ependymoma, glioblastomas and other astrocytic tumors. In addition, he has also initiated primary cell lines from breast cancer and oral-squamous cell carcinoma patients. Khan was awarded doctorate fellowship by King Abdulaziz University, where his research was focused on the molecular analysis of pathogenesis, pleomorphism, drug resistant, cancer stem cells, and unique genetic signatures of meningiomas, which resulted in discovery of AGR2 as a novel marker for aggressive brain tumors. Khan completed his Master research degree from University of Sunderland and his bachelor’s degree from University of Peshawar.